Phillip P. Chan, MD, PhD

Phillip P. Chan, MD, PhD

Chief Executive OfficeratCytosorbents· In proxies 2021–2025

Pay in FY2025-10% from the year before · Cytosorbents stock -29.8% the same year

Phillip P. Chan, MD, PhD was paid $808.4K in FY2025 (Dec), down 10%. Cytosorbents stock fell 29.8% that year.

Pay$100 in the stock at the end of FY20 → $8
Pay is from the Summary Compensation Table of each Cytosorbents proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CytosorbentsPublic company · 5 yr
    • Chief Executive Officer2021 – Present · 5 yrStock in role -97%
  2. Andrew TechnologiesPublic company
    • Director? – PresentNo stock prices for these years
  3. Medality Medical, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?